In the last 18 months, we got as high as 10c, before the drawback to these levels. Nothing has materially changed, although delays in Phase II data collection due to delays in obtaining FDA approval. Just a matter of time.
- Forums
- ASX - By Stock
- ACW
- Ann: Significant Advance in Development of Alzheimer's Drug
Ann: Significant Advance in Development of Alzheimer's Drug, page-10
Featured News
Add ACW (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.4¢ |
Change
-0.001(2.08%) |
Mkt cap ! $73.98M |
Open | High | Low | Value | Volume |
2.4¢ | 2.5¢ | 2.3¢ | $59.73K | 2.542M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 2790802 | 2.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.4¢ | 914088 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 2306498 | 0.023 |
11 | 3331171 | 0.022 |
8 | 1251904 | 0.021 |
9 | 1929400 | 0.020 |
8 | 2894884 | 0.019 |
Price($) | Vol. | No. |
---|---|---|
0.024 | 964088 | 8 |
0.025 | 786267 | 5 |
0.026 | 1293806 | 6 |
0.027 | 2722596 | 7 |
0.028 | 1155390 | 6 |
Last trade - 13.21pm 13/11/2024 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online